MEDICINES
PATIENT ASSISTANCE PROGRAMS
IMPORTED MEDICINES
CONTACT US
Upload
PRODUCT INTRODUCTION
Volibo 0.3 Tablet is a medication prescribed for the management of type 2 diabetes mellitus. It aids in regulating elevated blood sugar levels following meals. This medication is recommended when other similar treatments, in conjunction with a controlled diet, fail to adequately control excessively high blood sugar levels.
Volibo 0.3 Tablet is best taken immediately before a meal. Your doctor will determine the appropriate dosage and frequency to effectively regulate your blood sugar levels. Abruptly discontinuing the medication without consulting your doctor is not advisable. Doing so could lead to elevated blood sugar levels, increasing the risk of severe complications such as kidney damage and blindness.
This medication is just one component of a comprehensive treatment plan, which should also incorporate a balanced diet, consistent physical activity, and weight management as recommended by your physician. It’s essential to regularly monitor your blood sugar levels during the course of this medication.
The common adverse effects of Volibo 0.3 Tablet comprise flatulence (gas), stomach discomfort, decreased appetite, constipation, and diarrhea. If any of these side effects persist or become bothersome, it is advisable to consult your doctor. While this medication alone typically does not induce hypoglycemia (low blood sugar levels), caution is warranted when used alongside other diabetes medications, particularly insulin or sulphonylureas, as it may precipitate hypoglycemic episodes. In such instances, it is essential to address hypoglycemia promptly by consuming plain glucose, as table sugar or common sugar will not effectively correct low blood sugar levels when taking this medication.
Prior to initiating treatment, inform your doctor of any kidney or liver issues you may have. Refrain from using this medication if you are afflicted with bowel ulceration or inflammation (e.g., ulcerative colitis or Crohn’s disease). Pregnant or breastfeeding individuals should seek medical advice before commencing this medication. It is imperative to disclose all other medications you are currently taking to ensure your safety. Additionally, limit alcohol consumption while on this medication to mitigate the risk of hypoglycemia (low blood sugar levels).
USES OF VOLIBO TABLET
- Treatment of Type 2 diabetes mellitus
BENEFITS OF VOLIBO TABLET
In the treatment of Type 2 diabetes mellitus, Volibo 0.3 Tablet serves as a medication to regulate elevated blood glucose (sugar) levels. By slowing down the breakdown of food in the intestine into simple glucose (sugar), it effectively curbs the post-meal surge in blood glucose levels. Lowering blood glucose levels is pivotal in managing diabetes, as it diminishes the risk of developing severe complications such as kidney damage, eye issues, nerve complications, and limb loss.
For individuals with type 2 diabetes who already have cardiovascular disease, regular intake of Volibo 0.3 Tablet can decrease the risk of mortality from cardiovascular issues. Consistent usage of this medication, coupled with a balanced diet and regular exercise, promotes a normal, healthy lifestyle. It is imperative to adhere to the prescribed regimen, as Volibo 0.3 Tablet safeguards future health outcomes.
SIDE EFFECTS OF VOLIBO TABLET
The majority of side effects typically subside as your body acclimatizes to the medication and generally do not necessitate medical intervention. However, if any persist or cause concern, it is advisable to seek advice from your doctor.
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
HOW TO USE VOLIBO TABLET
Follow your doctor’s instructions regarding the dosage and duration of this medication. Swallow the tablet whole without chewing, crushing, or breaking it. Take Volibo 0.3 Tablet on an empty stomach.
HOW VOLIBO TABLET WORKS
Volibo 0.3 Tablet is classified as an anti-diabetic medication. It works by impeding the activity of intestinal enzymes responsible for converting complex sugars into simpler forms like glucose. This mechanism helps to prevent rapid spikes in blood glucose levels following meals.
SAFETY ADVICE
Pregnancy
Volibo 0.3 Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast Feeding
Volibo 0.3 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Liver
Volibo 0.3 Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Volibo 0.3 Tablet may be needed. Please consult your doctor.
Alcohol
It is unsafe to consume alcohol with Volibo 0.3 Tablet.
Driving
Volibo 0.3 Tablet does not usually affect your ability to drive.
WHAT IF YOU FORGET TO TAKE VOLIBO TABLET?
If you miss a dose of Volibo 0.3 Tablet, skip it and continue with your normal schedule. Do not double the dose.
FAQs
Q. Does Volibo 0.3 Tablet cause weight loss?
There is evidence that normal doses of Volibo 0.3 Tablet do not cause significant weight loss. However, very high doses of this medicine can affect the absorption of food, thereby causing weight loss. Do not take this medication for weight loss as it is not approved for the treatment of obesity. Do consult your doctor before starting this medication.
Q. How should you take Volibo 0.3 Tablet?
Volibo 0.3 Tablet is usually prescribed to be taken orally three times daily immediately before each meal. Volibo 0.3 Tablet may be given along with a controlled diet. However, in case Volibo 0.3 Tablet does not work alone, it may be given along with a proper diet and other antidiabetic medicines. Your doctor may further increase your doses if the given doses do not provide sufficient control over the blood sugar levels. Do not take this medication by yourself and consult your doctor before starting this medication.
Fact Box
Chemical Class: Valiolamine derivative
Habit Forming: No
Therapeutic Class: ANTI DIABETIC
Action Class: Alpha-glucosidase inhibitors
Reviews
There are no reviews yet.